Volume 23, Number 8—August 2017
Zika Virus Screening among Spanish Team Members After 2016 Rio de Janeiro, Brazil, Olympic Games
The current Zika virus epidemic became a major concern for national Olympic delegations before they traveled to Rio de Janeiro, Brazil, during summer 2016. Fear about individual consequences of the infection, such as congenital or neurologic disorders, were common among athletes and other participants of the Olympic Games and led some persons not to attend the Games for these reasons. The possibility of the Olympics contributing to a global spread of the Zika virus epidemic also was a concern, initially raised by ≈100 academic researchers, expressed in an open letter addressed to the World Health Organization (WHO) in May 2016 (1,2).
The risk for Zika during the Rio de Janeiro Olympic Games was estimated to be very low in different models published in medical journals (9 × 10−6 to 3 × 10−5) (3–6). After considering these figures, WHO advised that the Games should not substantially affect the epidemic (7).
To evaluate the risk for the Spanish Olympic Team acquiring Zika virus, our research group from 6 hospitals in Spain invited members of the Spanish delegation to participate in a serologic study of Zika virus 20 and 30 days after returning from Rio de Janeiro. The study was conducted in 6 different recruiting Tropical Medicine Units in cities in Spain (Barcelona, Madrid, Sevilla, San Sebastian, Las Palmas de Gran Canaria, and Almeria).
Athletes and other participants were invited to participate in the study through the Spanish Olympic Committee. A total of 117 Olympics participants accepted and were included in the study during September and October 2016. After providing oral and written information, study participants signed an informed consent form, and demographic and health data were recorded in a medical questionnaire. A total of 10 mL of blood was drawn from each participant, and serologic tests for Zika virus (immunofluorescence antibody assay; EUROIMMUN, Luebeck, Germany), dengue virus (ELISA; Panbio, Kyonggi-do, Republic of Korea), and chikungunya virus (immunofluorescence assay; EUROIMMUN) were conducted at the Instituto de Salud Carlos III (Spanish National Reference Laboratory, Madrid, Spain). For all samples initially testing positive for Zika virus, we conducted microneutralization testing.
Twenty-one participants had >1 signs or symptoms while in Brazil: 18% rash, 23% fever (temperature >38°C), 14% itching, 9% of conjunctival hyperemia, 9% arthralgia, 14% myalgia, 40% malaise, 9% lymphadenopathy, 32% headache, and 19% gastrointestinal symptoms. Ninety-nine percent of participants received Zika virus counseling before they traveled to Rio de Janeiro, including the advice of having protected sex during and after the Games (Table).
For 4 persons, test results for Zika virus IgG was positive; IgM and neutralization testing yielded negative results. The 4 Zika virus IgG–positive participants had received previous yellow fever vaccination and were asymptomatic. One sample showed Zika virus IgM in the absence of specific IgG; the results were confirmed in a follow-up sample. Thus, the sample was classified as false positive.
Study participants were advised to wait to conceive in accordance with WHO specifications: 6 months for men, 2 months for women. Participants with pregnant partners were advised to use condoms during the entire pregnancy.
A lack of Zika cases in this cohort supports the risk calculations made before the Games and the WHO statement that there were no Zika cases associated with the Olympic Games (8). Although 48% of participants in our study recalled at least 1 mosquito bite during the stay, the overall absence of cases in the Rio de Janeiro population during July and August 2016 (9,10) is believed to be due to the vector-control efforts by Brazilian authorities before the Games and to the winter weather, leading to a low presence of adult mosquitoes and mosquito bites (5,6).
Dr. Rodriguez-Valero is an internal medicine specialist working in travel medicine since 2015. Her research interests include new technologies in travel medicine, outbreaks, and emerging infectious diseases.
This work was supported by La Caixa Foundation and the Spanish Olympic Committee. The laboratory work was supported by RICET (Network Biomedical Research on Tropical Diseases), RD16CIII/003/003.
- World Health Organization. Zika virus and the Olympic and Paralympic Games Rio 2016 [cited 2016 Dec 26]. http://www.who.int/mediacentre/news/statements/2016/zika-olympics/en/
- Attaran A, Caplan A, Gaffney C, Igel L. Open letter to Dr. Margaret Chan, Director-General, WHO (copied to the International Olympic Committee) [cited 2017 June 9]. http://www.gannett-cdn.com/usatoday/editorial/sports/olympics/zika-olympics-open-letter.pdf
- Massad E, Tan S-H, Khan K, Wilder-Smith A. Estimated Zika virus importations to Europe by travellers from Brazil. Glob Health Action. 2016;9:31669. DOI
- Zumla A, McCloskey B, Bin Saeed AA, Dar O, Al Otabi B, Perlmann S, et al. What is the experience from previous mass gathering events? Lessons for Zika virus and the Olympics 2016. Int J Infect Dis. 2016;47:1–4. DOIPubMed
- Codeço C, Villela D, Gomes MF, Bastos L, Cruz O, Struchiner C, et al. Zika is not a reason for missing the Olympic Games in Rio de Janeiro: response to the open letter of Dr Attaran and colleagues to Dr Margaret Chan, Director - General, WHO, on the Zika threat to the Olympic and Paralympic Games. Mem Inst Oswaldo Cruz. 2016;111:414–5. DOIPubMed
- Grills A, Morrison S, Nelson B, Miniota J, Watts A, Cetron MS. Projected Zika virus importation and subsequent ongoing transmission after travel to the 2016 Olympic and Paralympic Games—country-specific assessment, July 2016. MMWR Morb Mortal Wkly Rep. 2016;65:711–5. DOIPubMed
- World Health Organization. Public health advice regarding the Olympics and Zika virus [cited 2016 Dec 26]. http://www.who.int/mediacentre/news/releases/2016/zika-health-advice-olympics/en/
- World Health Organization. Fourth meeting of the Emergency Committee under the International Health Regulations (2005) regarding microcephaly, other neurological disorders and Zika virus [cited 2016 Dec 26]. http://www.who.int/mediacentre/news/statements/2016/zika-fourth-ec/en/
- da Saude M. Secretaria de Vigilància em Saúde. Boletim Epidemiológico. Vol 47-no33.; Brasilia 2016 [cited 2017 June 11]. http://portalarquivos.saude.gov.br/images/pdf/2016/setembro/16/2016-028---Dengue-SE32.pdf
- da Saude M. Secretaria de Vigilància em Saúde. Boletim Epidemiológico. Vol 47-no34.; Brasilia 2016 [cited 2017 June 11]. http://portalsaude.saude.gov.br/images/pdf/2016/outubro/18/2016-029-Dengue-publicacao-n-34.pdf
No hay comentarios:
Publicar un comentario